美股市场个股详情
KNSA Kiniksa Pharmaceuticals International
- 21.280
- +0.190+0.90%
收盘价 11/22 16:00 (美东)
- 21.400
- +0.120+0.56%
盘后 17:59 (美东)
15.36亿总市值-177333市盈率TTM
21.480最高价21.117最低价19.19万股成交量21.160今开21.090昨收408.57万成交额1.14%换手率106.40市盈率(静)7220.16万总股本28.15052周最高3.52市净率3.59亿流通值15.52052周最低--股息TTM1685.89万流通股32.880历史最高--股息率TTM1.72%振幅5.010历史最低21.286平均价1股每手
关于Kiniksa Pharmaceuticals International公司
Kiniksa Pharmaceuticals International PLC是一家处于临床阶段的生物制药公司，致力于发现、收购、开发和商业化治疗衰弱性疾病患者的药物。该公司处于临床阶段的候选产品包括利纳西普、abiprubart、玛弗利木单抗。
公司介绍
公司代码KNSA
公司名称Kiniksa Pharmaceuticals International
上市日期2018/05/24
发行价格18.00
成立日期2024
CEOMr. Sanj K. Patel
所属市场纳斯达克
员工数量297
年结日12-31
公司地址23 Old Bond Street,3rd Floor
城市伦敦
省份大伦敦
国家英国
邮编W1S 4PZ
电话44-781-431-9100
董事高管
- 姓名
- 职务
- 年薪
- Sanj K. Patel
- Chief Executive Officer and Chairman of the Board
- 529.71万
- Michael R. Megna
- Chief Accounting Officer and Group Vice President, Finance
- --
- Eben Tessari
- Senior Vice President and Chief Operating Officer
- 175.21万
- Ross Moat
- Senior Vice President and Chief Commercial Officer
- --
- Mark Ragosa
- Senior Vice President and Chief Financial Officer
- --
- John F. Paolini, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 178.91万
- Cantey Boyd
- Director
- --
- Tracey L. McCain, Esq.
- Independent Director
- 36.54万
- Dr. Barry D. Quart,Pharm.D.
- Independent Director
- 37.26万
- Thomas R. Malley
- Independent Director
- 38.04万
- G. Bradley Cole
- Independent Director
- 36.54万
- Dr. Stephen R. Biggar,M.D.,PhD
- Independent Director
- 37.20万
- Dr. Richard S. Levy,M.D.
- Independent Director
- 45.97万
- Dr. Felix J. Baker,PhD
- Lead Independent Director
- 41.11万
- Kimberly J. Popovits
- Independent Director
- 36.27万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据